04-01-2021||New Delhi||Xiaomi stops roll-out of Mi A3 devices after users’ complaints||Smart devices maker Xiaomi has stopped the roll-out of Mi A3 in India after users complained about technical glitch following an Android update.Most of the users on social media platforms complained that their phones went dead or freezed after they installed a new update of Android 11.“We are aware of the issue on some Mi A3 devices following a recent Android 11 update. We have since halted the roll-out,” Xiaomi India said in a statement.The device was launched in India on August 21 for Rs 12,999.Some users complained about Xiaomi centres demanding high price for repair of phones. The company announced that the issue of all affected users will be resolved at service centres for free irrespective of the product warranty.“We kindly request users who experience this issue to visit any of the 2,000-plus service centres across the country nearer to you, wherein a solution will be provided for free unconditionally, within or beyond warranty,” Xiaomi said.Xiaomi led the India smartphone market in the third quarter of 2020, with a 25 per cent market share and grew 7.1 per cent on a year-on-year basis, according to market research firm IDC.“We regret the inconvenience this has brought about. As a brand committed to offering the best possible user experience, we will continuously improve our products and services,” Xiaomi said. PTI||https://www.tribuneindia.com/news/business/xiaomi-stops-roll-out-of-mi-a3-devices-after-users-complaints-193643
04-01-2021||Mumbai||Buying on decline: Markets rise post slide; IT stocks shine||Indian equity markets posted healthy recovery after an intra-day slide as investors took the opportunity to 'buy on decline'.In the intra-day, market opened with a 'gap up' as positive macro indicators and vaccine advances in India buoyed sentiments.Consequently, the S&P BAE Sensex crossed the 48,000-mark.However, the market could not sustain itself at higher zones.Just after the initial session, the key indices fell by around 150 points.Subsequently, investors dived into the market to buy stocks in decline which triggered another uplift.Amongst sectors, losses were witnessed in realty, media, banking and financial services indices.On the other hand, metals, IT, pharma, auto and FMCG space traded in the green.Besides, healthy FII activity was witnessed.At 1.40 p.m., the NSE Nifty50 traded at 14,099.15 points, higher by 80.65 points, or 0.58 per cent, from its previous close.Similarly, the BSE Sensex made gains. It traded higher by 192.28 points, or 0.40 per cent, to 48,061.26 points from its previous close."Considering overall chart structure, we are expecting Nifty to hold above 14000 zone and move towards 14250 -14300 zone in coming days," said Jay Purohit, Technical & Derivatives Analyst, MOFSL."While support can be seen at 13850 and then 13,777 levels. On stocks front, traders can look for buying opportunities in Tata Steel, Page Inds, Gail and SBI Cards."According to Likhita Chepa, Senior Research Analyst at CapitalVia Global Research: "On Monday, the markets hit new highs in early trading, powered by strong macro indicators and vaccine advances in India. For the first time ever, the Sensex crossed the 48,000-mark. But soon after hitting the new peaks market went off the day's high.""Asian stocks have been mixed today as vaccine optimism has outweighed concern about growing numbers of infections globally. For the Nifty, 14100 might indicate a resistance. We suggest booking profits at current juncture and trail thereon. At 13,900, we have strong support."IANS||https://www.tribuneindia.com/news/business/buying-on-decline-markets-rise-post-slide-it-stocks-shine-193569
04-01-2021||Mumbai||Rupee surges 21 paise to 72.90 against US dollar in early trade||The rupee appreciated by 21 paise to 72.90 against the US dollar in opening trade on Monday supported by sustained foreign fund inflows and weakness of the American currency in the overseas market.Traders said hopes of COVID-19 vaccine also improved sentiments.India's drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.At the interbank forex market, the domestic unit opened at 72.93 against the US dollar and inched higher to 72.90 against the greenback, registering a rise of 21 paise over its previous close.On Friday, the rupee had settled at 73.11 against the American currency.Meanwhile, the dollar index, which gauges the greenback's strength against a basket of six currencies, fell 0.24 per cent to 89.72."An improving global economic outlook as COVID-19 vaccines are rolled out, rock-bottom US interest rates and ongoing Fed bond purchases have dented the dollar's appeal," Reliance Securities said.Further, "most Asian currencies were trading stronger against the greenback this morning and could lend support to the domestic unit," it added.On the domestic equity market front, the benchmark BSE Sensex and the broader NSE index touched fresh record-high levels in early deals. The 30-share BSE benchmark Sensex was trading 224.28 points higher at 48,093.26, and the broader NSE Nifty was up 74.85 points at 14,093.35.Foreign institutional investors were net buyers in the capital market as they purchased shares worth Rs 506.21 crore on a net basis on Friday, according to provisional exchange data.Brent crude futures, the global oil benchmark, advanced 1.06 per cent to USD 52.35 per barrel. PTI||https://www.tribuneindia.com/news/business/rupee-surges-21-paise-to-72-90-against-us-dollar-in-early-trade-193512
04-01-2021||Mumbai||Sensex jumps nearly 300 pts in early trade; Nifty tops 14,100||Equity benchmark Sensex jumped nearly 300 points in opening trade on Monday, tracking gains in index majors ITC, Infosys and ICICI Bank as investors cheered domestic COVID-19 vaccine approvals.The 30-share BSE index touched its lifetime intra-day high of 48,168.22 in early trade. It was trading 272.73 points or 0.57 per cent higher at 48,141.71, and the broader NSE Nifty surged 90.90 points or 0.65 per cent to a record high of 14,109.40.TCS was the top gainer in the Sensex pack, rising around 2 per cent, followed by ONGC, SBI, L&T, Infosys, HCL Tech, ICICI Bank and Axis Bank.On the other hand, HDFC, Asian Paints and Reliance Industries were among the laggards.In the previous session, Sensex rose by 117.65 points or 0.25 per cent to close at a fresh lifetime-high of 47,868.98, while Nifty closed at an all-time high of 14,018.50.Foreign portfolio investors (FPIs) were net buyers in the capital market as they purchased shares worth Rs 506.21 crore on a net basis on Friday, according to provisional exchange data.Domestic equities continue to look firm. Strong economic key data in terms of GST collections, power demand and railway freight for December 2020 will continue to offer strength to the market, said Binod Modi Head-Strategy at Reliance Securities.Additionally, final approval for two COVID-19 vaccines and likely commencement of the inoculation process soon are positive for the markets and economy."Positive FPI flows are expected to sustain in subsequent weeks. Further, DIIs turning net buyers on Friday was also a positive indication for the market. 3QFY21 earnings and Union Budget will be crucial events for the market in the near term, which will offer clarity about the sustainability of demand momentum," he stated.Elsewhere in Asia, bourses in Shanghai, Seoul and Hong Kong were trading on a positive note in mid-session deals, while Tokyo was in the red.Meanwhile, the global oil benchmark, Brent crude futures, were trading 0.98 per cent higher at USD 52.31 per barrel. PTI||https://www.tribuneindia.com/news/business/sensex-jumps-nearly-300-pts-in-early-trade-nifty-tops-14-100-193501
